Reneo Pharmaceuticals Appoints Roshawn Blunt to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
02.08.2022 - IRVINE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) - Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic mitochondrial .
Reneo Pharmaceuticals Appoints Eric Dube, Ph.D. to its Board of Directors
March 15, 2021 08:00 ET | Source: Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. Sani Diego, California, UNITED STATES
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced the appointment of Eric Dube, Ph.D. to the company’s Board of Directors.
“We are very pleased to announce the addition of Eric Dube to the Reneo Board,” said Gregory J. Flesher, President and Chief Executive Officer of Reneo. “Eric is an accomplished pharmaceutical industry executive and a leader in the rare disease field. We look forward to his guidance and insights as we work to advance REN001 and lead Reneo to its next phase of development.”